Venous thromboembolism following prolonged cast immobilisation for injury to the tendo Achillis

Journal of Bone and Joint Surgery - Series B

Volumn 92, Issue 5, 2010, Pages 646-650

  Healy, B ^a,b   Beasley, R ^a,b   Weatherall, M ^a,c  

^a WELLINGTON HOSPITAL   (New Zealand)

^b MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; HIP ARTHROPLASTY; HUMAN; IMMOBILIZATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PLASTER CAST; PRIORITY JOURNAL; RISK FACTOR; TENDON INJURY; VENOUS THROMBOEMBOLISM;

ACHILLES TENDON; ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; CASTS, SURGICAL; FEMALE; HUMANS; IMMOBILIZATION; MALE; MEDICAL AUDIT; MEDICAL RECORDS; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PULMONARY EMBOLISM; RISK FACTORS; TIME FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 77951874438     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.92B5.23241     Document Type: Article

References (27)

1. Bergqvist D, Lowe G. Venous thromboembolism in patients undergoing laparoscopic and arthroscopic surgery and in leg casts. Arch Intern Med 2002;162:2173-2176 (Pubitemid 35231584)
2. Kujath P, Spannagel U, Habscheid W. Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis 1993;23(Suppl 1):20-26 (Pubitemid 23116270)
3. Lassan MR, Borris LC, Nakov RL. Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization. N Engl J Med 2002;347:726-730
4. Ettema HB, Kollen BJ, Verheyen CC, Büller HR. Prevention of venous thromboembolism in patients with immobilization of the lower limb extremities: a meta-analysis of randomized controlled trials. J Thromb Haemost 2008;6:1093-1098
5. Testroote M, Stigter W, de Visser DC, Janzing H. Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization. Cochrane Database Syst Rev 2008;4:CD006681. (Pubitemid 351805561)
6. Kock HJ, Schmit-Neuerburg KP, Hanke J, Rudofsky G, Hirche H. Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilization of the leg. Lancet 1995;346:459-461
7. Jørgensen PS, Warming T, Hansen K, et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast: a venografic controlled study. Thromb Res 2002;105:477-480
8. Lapidus LJ, Rosfors S, Ponzer S, et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo-controlled study. J Orthop Trauma 2007;21:52-57
9. Lapidus LJ, Ponzer S, Elvin A, et al. Prolonged thromboprophylaxis with dalteparin during immobilization after ankle fracture surgery: a randomized placebo-controlled, double-blind study. Acta Orthop 2007;78:528-535
10. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007;116:427-433
11. Nokes TJ, Keenan J. Thromboprophylaxis in patients with lower limb immobilisation: review of current status. Br J Haematol 2009;146:361-368
12. Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg [Am] 2000;82-A:929-938
13. White RH, Romano PS, Zhou H, Rodrigo J, Bargar W. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998;158:1525-1531 (Pubitemid 28340985)
14. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-ased Clinical Practice Guidelines (8th Edition). Chest 2008;133 (Suppl):381-453. (Pubitemid 351894916)
15. No authors listed. Prophylaxis of venous thromboembolism: a national clinical guideline. Scottish Intercollegiate Guidelines Network 2002;62:17-20 http://www.sign.ac.uk/pdf/ sign62.pdf (date last accessed 29 January 2010).
16. No authors listed. Collaborative overview of randomised trials of antiplatelet therapy. III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients: Antiplatelet Trialists' Collaboration. BMJ 1994;308:235-246
17. No authors listed. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000;355:1295-1302
18. Sarmiento A, Goswami AD. Thromboembolic prophylaxis with use of aspirin, exercise, and graded elastic stockings or intermittent compression devices in patients managed with total hip arthroplasty. J Bone Joint Surg [Am] 1999;81-A:339-346 (Pubitemid 29153211)
19. Karthikeyan G, Eikelboom JW, Turpie AG, Hirsh J. Does acetyl salicyclic acid (ASA) have a role in the prevention of venous thromboembolism? Br J Haematol 2009;146:142-149
20. Eriksson BI, Dahl OE, Rosencher N, et al; RE-NOVATE Study Group. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet 2007;370:949-956 (Pubitemid 47393577)
21. Eriksson BI, Dahl OE, Büller HR, et al. A new oral direct thrombin inhibitor, dabigatran etexilate, compared with, enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Thromb Haemost 2005;3:103-111
22. Wolowacz SE, Roskell NS, Plumb JM, Caprini JA, Eriksson BI. Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty: a meta-analysis. Thromb Haemost 2009;101:77-85.
23. Fisher WD, Eriksson BI, Bauer KA, et al. Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies. Thromb Haemost 2007;97:931-937
24. Eriksson BI, Borris LC, Friedman RJ, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 2008;358:2765-2775
25. Lassen MR, Ageno W, Borris LC, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 2008;358:2776-2786
26. Turpie AG, Lassen MR, Davidson BL, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet 2009;373:1673-1680
27. Eriksson BI, Kakkar AK, Turpie AG, et al. Oral rivaroxaban for the prevention of symptomatic venous thromboembolism, after elective hip and knee replacement. J Bone Joint Surg [Br] 2009;91-B:636-644